4 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: December 21, 2023
As we reach the end of 2023 and yet another remarkable year at Cleerly, it’s a great opportunity to reflect on all we’ve accomplished and begin...
2 min read
Cleerly: November 3, 2023
Cleerly has had a busy few months – attending conferences, panel sessions, and winning awards as we all work together to achieve our mission of a...
4 min read
Cleerly: February 27, 2023
Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk...
3 min read
Cleerly: February 27, 2023
Care quality is a pillar of the Quadruple Aim for a reason. Stakeholders across the healthcare ecosystem benefit when patients have access to the...
3 min read
Cleerly: November 9, 2022
Cleerly’s Medical Affairs team had the opportunity to present at the American Heart Association’s (AHA) 2022 Scientific Sessions this past week in...
3 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: September 19, 2022
Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.
3 min read
Cleerly: March 11, 2022
There's a little-known fact in cardiology: Most of the care that's provided doesn't prevent heart attacks.
1 min read
Cleerly: March 7, 2022
Cleerly CEO James Min, M.D., is a guest on the latest episode of the AWS Health Innovation Podcast hosted by Joe Shonkwiler, M.D.
3 min read
Cleerly: February 14, 2022
Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease...
2 min read
Cleerly: February 8, 2022
As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...
